Literature DB >> 29142606

Hesperidin inhibits ovarian cancer cell viability through endoplasmic reticulum stress signaling pathways.

Jun Zhao1, Yali Li1, Jinfang Gao2, Yinshan De2.   

Abstract

Hesperidin is a vitamin P flavonoid compound primarily present in citrus fruits. The aim of the present study was to investigate whether hesperidin inhibits ovarian cancer cell viability via endoplasmic reticulum stress signaling pathways. A2780 cells were treated with various doses of hesperidin for 6, 12 or 24 h, and the viability of A2780 cells was assessed using the MTT assay. Hesperidin decreased the viability of A2780 cells and increased cytotoxicity in a dose- and time-dependent manner. In addition, hesperidin induced apoptosis and increased cleaved caspase-3 protein expression levels in A2780 cells. Furthermore, hesperidin markedly increased the protein expression of anti-growth arrest- and DNA damage-inducible gene 153, anti-CCAAT'enhancer-binding protein homologous protein, glucose-regulated protein 78 and cytochrome c in A2780 cells. The results of the present study indicated that hesperidin inhibits cell viability and induces apoptosis in ovarian cancer cells via endoplasmic reticulum stress signaling pathways. Thus, hesperidin may offer a novel therapeutic tool for ovarian carcinoma.

Entities:  

Keywords:  endoplasmic reticulum stress; hesperidin; ovarian cancer

Year:  2017        PMID: 29142606      PMCID: PMC5666666          DOI: 10.3892/ol.2017.6873

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  38 in total

Review 1.  Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models.

Authors:  Hamideh Parhiz; Ali Roohbakhsh; Fatemeh Soltani; Ramin Rezaee; Mehrdad Iranshahi
Journal:  Phytother Res       Date:  2014-11-13       Impact factor: 5.878

2.  ERS-PERK signaling pathway-mediated Nrf2/ARE-HO-1 axis: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury.

Authors:  Jichun Wang; Xiaorong Hu; Hong Jiang
Journal:  Int J Cardiol       Date:  2015-11-10       Impact factor: 4.164

3.  ATF4 activation by the p38MAPK-eIF4E axis mediates apoptosis and autophagy induced by selenite in Jurkat cells.

Authors:  Qian Jiang; Feng Li; Kejian Shi; Pa Wu; Jiajia An; Yang Yang; Caimin Xu
Journal:  FEBS Lett       Date:  2013-06-19       Impact factor: 4.124

4.  Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.

Authors:  Alexander C Adam; Alexander Scriba; Monika Ortmann; Sebastian Huss; Philip Kahl; Susanne Steiner; Stephan Störkel; Reinhard Büttner
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-01

5.  A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study).

Authors:  Yutaka Ueda; Takashi Miyatake; Masaaki Nagamatsu; Masato Yamasaki; Yukihiro Nishio; Kiyoshi Yoshino; Masami Fujita; Tateki Tsutsui; Takayuki Enomoto; Tadashi Kimura
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-07-20       Impact factor: 2.435

6.  Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells.

Authors:  Zeynep Birsu Cincin; Miray Unlu; Bayram Kiran; Elif Sinem Bireller; Yusuf Baran; Bedia Cakmakoglu
Journal:  Cell Oncol (Dordr)       Date:  2015-04-10       Impact factor: 6.730

7.  Betulinic acid induces Bax/Bak-independent cytochrome c release in human nasopharyngeal carcinoma cells.

Authors:  Yang Liu; Wenlong Luo
Journal:  Mol Cells       Date:  2012-04-17       Impact factor: 5.034

8.  Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma.

Authors:  Todd D Tillmanns; M Patrick Lowe; Mark S Walker; Edward J Stepanski; Lee S Schwartzberg
Journal:  Gynecol Oncol       Date:  2012-09-05       Impact factor: 5.482

9.  CGK733-induced LC3 II formation is positively associated with the expression of cyclin-dependent kinase inhibitor p21Waf1/Cip1 through modulation of the AMPK and PERK/CHOP signaling pathways.

Authors:  Yufeng Wang; Yasuhiro Kuramitsu; Byron Baron; Takao Kitagawa; Kazuhiro Tokuda; Junko Akada; Kazuyuki Nakamura
Journal:  Oncotarget       Date:  2015-11-24

10.  Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo.

Authors:  D P Gately; J A Jones; R Christen; R M Barton; G Los; S B Howell
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  7 in total

Review 1.  Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements.

Authors:  Vaishali Aggarwal; Hardeep S Tuli; Falak Thakral; Paavan Singhal; Diwakar Aggarwal; Saumya Srivastava; Anjana Pandey; Katrin Sak; Mehmet Varol; Md Asaduzzaman Khan; Gautam Sethi
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-12

Review 2.  An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent.

Authors:  Ipek Suntar; Haroon Khan; Seema Patel; Rita Celano; Luca Rastrelli
Journal:  Oxid Med Cell Longev       Date:  2018-05-02       Impact factor: 6.543

3.  Dietary Polyphenols-Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review.

Authors:  Wojciech Koch
Journal:  Nutrients       Date:  2019-05-09       Impact factor: 5.717

Review 4.  Benefits of Hesperidin for Cutaneous Functions.

Authors:  Mao-Qiang Man; Bin Yang; Peter M Elias
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-02       Impact factor: 2.629

Review 5.  Phytochemicals in Gynecological Cancer Prevention.

Authors:  Marta Woźniak; Rafał Krajewski; Sebastian Makuch; Siddarth Agrawal
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

Review 6.  Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review.

Authors:  Md Sohel; Habiba Sultana; Tayeba Sultana; Md Al Amin; Suraiya Aktar; Md Chayan Ali; Zahed Bin Rahim; Md Arju Hossain; Abdullah Al Mamun; Mohammad Nurul Amin; Raju Dash
Journal:  Heliyon       Date:  2022-01-23

7.  7-Isopenthenyloxycoumarin, Arctigenin, and Hesperidin Modify Myeloid Cell Leukemia Type-1 (Mcl-1) Gene Expression by Hormesis in K562 Cell Line.

Authors:  Zahra Kafi; Hamid Cheshomi; Omid Gholami
Journal:  Dose Response       Date:  2018-09-11       Impact factor: 2.658

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.